Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3

Fig. 2

Analysis of relative expression of circADARB1 and clinical data of NKTCL patients. A Comparison of the relative expression of circADARB1 in the plasma of NKTCL patients and healthy controls; B ROC curve of circADARB1; C Comparison of the relative expression of circADARB1 in NKTCL patients with different efficacy; D three-year survival curve. *P < 0.05, ***P < 0.001

Back to article page